Kangji Medical's (HKG:9997) associate, Hangzhou Weijing Medical Robot, obtained regulatory approval from China's National Medical Products Administration for its proprietary four-arm laparoscopic surgical robot, a Tuesday Hong Kong bourse filing said.
The clearance covers clinical applications in urological, gynecological, and general surgical laparoscopic procedures.
Surgical device maker Kangji Medical directly holds around 41.99% equity interest in Hangzhou Weijing Medical Robot.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.